Clinical Trials Directory

Trials / Completed

CompletedNCT00785395

Up-Down Oxytocin Infusion

Up-down Determination of the ED90 of Oxytocin Infusions for the Prevention of Postpartum Uterine Atony in Parturients Undergoing Cesarean Delivery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (actual)
Sponsor
IWK Health Centre · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is designed to determine the minimum effective dose (ED90) of infusions of oxytocin for the prevention of uterine atony / postpartum hemorrhage and the need for additional uterotonics, in low risk parturients presenting for an elective CD. The primary outcome measure is the response of effective uterine contraction as either satisfactory or unsatisfactory as determined by the obstetrician blinded to the oxytocin infusion dose. Secondary outcomes will include need for additional uterotonics, calculated intra-operative blood loss and presence of oxytocin related adverse effects.

Conditions

Interventions

TypeNameDescription
DRUGOxytocin infusionUp-down dosing determination

Timeline

Start date
2008-06-01
Primary completion
2008-08-01
Completion
2008-08-01
First posted
2008-11-05
Last updated
2011-11-02

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00785395. Inclusion in this directory is not an endorsement.